Correcting Microsomal Clearance for Incubation Binding

Why Correct Microsomal Clearance for Binding?

A microsomal assay measures substrate disappearance in an incubation containing microsomal protein. Some substrate may bind reversibly to microsomal membranes or other components of the incubation. If the measured disappearance is interpreted relative to the total substrate concentration, binding can make the apparent clearance smaller than the clearance referenced to the substrate that is unbound and available to enzymes. The correction uses the unbound fraction in the incubation, not the unbound fraction in plasma.

The introductory material on measuring unbound fraction in microsomal incubations establishes how an assay can estimate this fraction. Here the focus is the quantitative link between that estimate and apparent microsomal clearance. The correction is simple, but it is meaningful only when its assumptions and units are clear.

Definition: Let \(f_{u,\mathrm{inc}}\) be the fraction of the total substrate concentration in a microsomal incubation that is unbound. Let \(CL_{\mathrm{int,app}}\) be apparent intrinsic clearance calculated using total incubation concentration, with units such as mL/min/mg microsomal protein. Under the assumptions below, unbound intrinsic clearance is \(CL_{\mathrm{int,u}}=CL_{\mathrm{int,app}}/f_{u,\mathrm{inc}}\), in the same clearance units.

Deriving the Correction

For a low substrate concentration at which metabolic rate is proportional to unbound substrate concentration, define \(CL_{\mathrm{int,u}}\) as the rate of metabolic disappearance per unit microsomal protein divided by the unbound substrate concentration. Write \(P\) for microsomal protein concentration and \(C_{\mathrm{tot}}\) and \(C_u\) for total and unbound substrate concentrations in the incubation. The rate per incubation volume is then

v = P\,CL_{\mathrm{int,u}}\,C_u

If binding is at equilibrium and \(f_{u,\mathrm{inc}}\) is constant over the interval used to estimate clearance, \(C_u=f_{u,\mathrm{inc}}C_{\mathrm{tot}}\). Substitution gives

v = P\,CL_{\mathrm{int,u}}\,f_{u,\mathrm{inc}}\,C_{\mathrm{tot}}

Apparent clearance per unit microsomal protein is the disappearance rate divided by \(P\) and by total substrate concentration. Therefore,

CL_{\mathrm{int,app}} = \frac{v}{P\,C_{\mathrm{tot}}} = f_{u,\mathrm{inc}}CL_{\mathrm{int,u}}

Rearranging gives the correction. Since \(f_{u,\mathrm{inc}}\) is a fraction between zero and one, dividing by it increases or leaves unchanged the apparent clearance. For example, if \(f_{u,\mathrm{inc}}=0.20\), the unbound estimate is five times the apparent estimate. This is an algebraic consequence of the model, not evidence that the true in vivo clearance is five times larger.

Assumptions: The substrate is in a concentration range where the metabolic rate is proportional to unbound substrate concentration; binding is sufficiently rapid and reversible for \(C_u=f_{u,\mathrm{inc}}C_{\mathrm{tot}}\) to apply; the measured unbound fraction represents the metabolic incubation conditions; and measured disappearance reflects metabolism rather than substantial non-metabolic loss. The assay conditions also must not cause important changes in enzyme activity during the clearance measurement.

For substrate-depletion data, a common calculation first estimates a first-order depletion rate constant \(k_{\mathrm{dep}}\) from the decline in total substrate concentration. Under first-order depletion, \(C_{\mathrm{tot}}(t)=C_{\mathrm{tot}}(0)e^{-k_{\mathrm{dep}}t}\), and \(k_{\mathrm{dep}}=0.693/t_{1/2}\) when the half-life is estimated from that decline. If \(P\) is the microsomal protein concentration, then \(CL_{\mathrm{int,app}}=k_{\mathrm{dep}}/P\). Combining this with the binding correction gives

CL_{\mathrm{int,u}} = \frac{k_{\mathrm{dep}}}{P\,f_{u,\mathrm{inc}}}

The units check: \(k_{\mathrm{dep}}\) has units of inverse time and \(P\) has units of mass per volume, so \(k_{\mathrm{dep}}/P\) has units of volume per time per mass. The unbound fraction is dimensionless and does not change those units.

Worked Calculations

Worked Example: Correcting Clearance From a Depletion Half-Life

In a hypothetical assay, substrate depletion has an estimated half-life of 30.0 minutes. The incubation contains 0.500 mg microsomal protein per mL, and a binding measurement under matched conditions gives \(f_{u,\mathrm{inc}}=0.300\). Calculate apparent and unbound intrinsic clearance.

First calculate the depletion rate constant:

k_{\mathrm{dep}}=\frac{0.693}{30.0\ \mathrm{min}} =0.0231\ \mathrm{min}^{-1}

Then divide by protein concentration to obtain apparent clearance:

CL_{\mathrm{int,app}} =\frac{0.0231\ \mathrm{min}^{-1}}{0.500\ \mathrm{mg/mL}} =0.0462\ \mathrm{mL/min/mg}

Finally, correct for incubation binding:

CL_{\mathrm{int,u}} =\frac{0.0462\ \mathrm{mL/min/mg}}{0.300} =0.154\ \mathrm{mL/min/mg}

Under the stated assumptions, the result is an unbound intrinsic clearance of 0.154 mL/min/mg microsomal protein. It is 3.33 times the apparent estimate because \(1/0.300=3.33\).

Worked Example: Applying a Supplied Apparent Clearance

A hypothetical study reports \(CL_{\mathrm{int,app}}=12.0\ \mathrm{\mu L/min/mg}\) from a microsomal depletion assay. The unbound fraction in the same incubation conditions is estimated as 0.0800. What is the corrected clearance?

Apply the ratio directly, keeping the clearance units unchanged:

CL_{\mathrm{int,u}} =\frac{12.0\ \mathrm{\mu L/min/mg}}{0.0800} =150\ \mathrm{\mu L/min/mg}

The corrected value is 150 \(\mathrm{\mu L/min/mg}\), or 0.150 \(\mathrm{mL/min/mg}\). The arithmetic is valid only if the supplied fraction describes the same incubation matrix and relevant conditions as the clearance assay. A value measured in a different matrix cannot be substituted just because it is available.

Worked Example: Checking Matched Assay Conditions

Two hypothetical assays use different microsomal protein concentrations for the same compound. In condition A, \(P=0.500\ \mathrm{mg/mL}\), \(k_{\mathrm{dep}}=0.0300\ \mathrm{min}^{-1}\), and \(f_{u,\mathrm{inc}}=0.200\). In condition B, \(P=0.250\ \mathrm{mg/mL}\), \(k_{\mathrm{dep}}=0.0375\ \mathrm{min}^{-1}\), and \(f_{u,\mathrm{inc}}=0.500\). Calculate both corrected clearances.

For condition A:

CL_{\mathrm{int,app,A}} =\frac{0.0300}{0.500} =0.0600\ \mathrm{mL/min/mg}, \qquad CL_{\mathrm{int,u,A}} =\frac{0.0600}{0.200} =0.300\ \mathrm{mL/min/mg}

For condition B:

CL_{\mathrm{int,app,B}} =\frac{0.0375}{0.250} =0.150\ \mathrm{mL/min/mg}, \qquad CL_{\mathrm{int,u,B}} =\frac{0.150}{0.500} =0.300\ \mathrm{mL/min/mg}

The apparent values differ, but the corrected values agree. In this example the difference in apparent clearance is consistent with the different unbound fractions: \(0.200\times0.300=0.0600\) in condition A and \(0.500\times0.300=0.150\) in condition B. Agreement does not prove that every assay assumption holds, but a large disagreement after a properly matched correction would be a reason to investigate assay conditions, measurement error, or departures from the simple model.

Diagnostics, Alternatives, and Limits

Before using the corrected estimate, check how the clearance and unbound fraction were obtained. If clearance comes from depletion, inspect whether the analysed decline is approximately log-linear over the fitted interval and whether the estimated rate is distinguishable from background loss. Check that the microsomal protein concentration is the concentration in the incubation used for the depletion estimate, and that the binding measurement represents that concentration and the relevant incubation composition. A binding fraction from a different protein concentration, substrate concentration, or matrix may not describe the assay being corrected.

The correction is especially sensitive when \(f_{u,\mathrm{inc}}\) is small. For example, dividing by 0.05 multiplies the apparent value by 20. Small absolute errors in a low unbound fraction can then cause substantial changes in the corrected clearance. Report the fraction and its measurement conditions alongside the corrected value; do not present a highly amplified result as more precise than its inputs allow.

The simple derivation assumes proportionality between rate and unbound concentration. If substrate concentrations approach a range where metabolism is saturated, a single clearance may depend on concentration, and the depletion curve may not be first-order. A constant fraction correction may then be inadequate for the whole curve; the rate relationship and binding need to be considered across the concentrations relevant to the estimate. Likewise, this correction does not repair substantial nonspecific substrate loss, an inappropriate depletion fit, or changes in enzyme activity during incubation.

There are three practical approaches. First, when binding is negligible and \(f_{u,\mathrm{inc}}\) is near one, the apparent clearance is already close to the unbound estimate; report the measured fraction and the reason a numerical correction has little effect. Second, when binding is material and the assumptions are reasonable, apply \(CL_{\mathrm{int,app}}/f_{u,\mathrm{inc}}\). Third, if a reliable unbound concentration can be measured directly in the metabolic assay, clearance can be calculated relative to that concentration; under the same model this is the same correction expressed through its denominator. Using plasma unbound fraction instead is not an alternative: plasma and microsomal incubation are different matrices, and their unbound fractions are not interchangeable.

This is a correction to an in vitro intrinsic-clearance estimate. It is not, by itself, a prediction of whole-organ or systemic clearance. Further scaling and physiological modeling are separate steps, and the binding correction does not address biases arising elsewhere in the IVIVE chain.

Common Pitfall

Common mistake: “Only 20% is unbound, so multiply apparent clearance by 0.20 to account for binding.” This moves the estimate in the wrong direction. Apparent clearance is rate divided by total concentration, while the unbound clearance is rate divided by the smaller unbound concentration. Since \(CL_{\mathrm{int,app}}=f_{u,\mathrm{inc}}CL_{\mathrm{int,u}}\), the correction is division: \(CL_{\mathrm{int,u}}=CL_{\mathrm{int,app}}/f_{u,\mathrm{inc}}\). Multiplication would reduce the estimate and contradict the derived relationship.

Check Your Understanding

Use the assumptions and equations above. Each answer is included so you can check the reasoning.

An assay gives \(CL_{\mathrm{int,app}}=0.0400\ \mathrm{mL/min/mg}\) and \(f_{u,\mathrm{inc}}=0.250\). Calculate \(CL_{\mathrm{int,u}}\).
Why must the unbound fraction represent the microsomal incubation rather than plasma?
A depletion curve is strongly non-linear on a log-concentration scale. What assumption should be questioned before applying the half-life calculation?
If \(f_{u,\mathrm{inc}}=1.00\), what relationship should hold between apparent and unbound intrinsic clearance?

Solutions. 1. \(0.0400/0.250=0.160\ \mathrm{mL/min/mg}\). 2. The correction uses the fraction unbound in the matrix where the metabolic rate was measured; plasma is a different matrix and need not have the same fraction. 3. First-order depletion, which is required for a single constant \(k_{\mathrm{dep}}\) and half-life-based apparent clearance, should be questioned; saturation or other departures may be present. 4. They should be equal, because dividing by \(f_{u,\mathrm{inc}}=1.00\) leaves the apparent clearance unchanged.